Boston Scientific (BSX) Restructuring Costs (2009 - 2026)

Boston Scientific has disclosed Restructuring Costs across 18 years of filings, most recently posting $3.0 million for Q1 2026.

• Restructuring Costs for Q1 2026 came in at $3.0 million, down 70.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $94.0 million (up 1242.86% YoY), and the FY2025 annual result was $101.0 million, changed N/A from the prior year.
• Restructuring Costs came in at $3.0 million for Q1 2026 at Boston Scientific, down from $16.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $131.0 million in Q4 2022 to a low of -$111.0 million in Q3 2023.
• The 5-year median for Restructuring Costs is $8.0 million (2024), against an average of $13.7 million.
• Peak annual rise in Restructuring Costs reached 8200.0% in 2025, while the deepest fall reached 200.0% in 2025.
• Boston Scientific's Restructuring Costs stood at $131.0 million in 2022, then tumbled by 184.73% to -$111.0 million in 2023, then soared by 89.19% to -$12.0 million in 2024, then jumped by 233.33% to $16.0 million in 2025, then plunged by 81.25% to $3.0 million in 2026.
• The last three Restructuring Costs figures came in at $3.0 million (Q1 2026), $16.0 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.